13 laws and 12 links: citations, amendments, and UK copies of EU law. Bigger circles are relied on more.
| Law | Links on map | Importance |
|---|---|---|
| EUDirective 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use | 1 | 0.25 |
| EUDirective 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products | 1 | 0.18 |
| EUAbraxis Bioscience LLC v Comptroller General of Patents (C-443/17) | 12 | 0.00 |
| EUSanten SAS v Directeur général de l’Institut national de la propriété industrielle (C-673/18) | 1 | 0.00 |
| EUNeurim Pharmaceuticals (1991) Ltd v Comptroller-General of Patents (C-130/11) | 1 | 0.00 |
| EUC-119/22 Teva and Others | 1 | 0.00 |
| EUF. Hoffmann-La Roche Ltd and Others v Autorità Garante della Concorrenza e del Mercato (C-179/16) | 1 | 0.00 |
| EUMedeva BV v Comptroller General of Patents, Designs and Trade Marks (C-322/10) | 1 | 0.00 |
| EURoyalty Pharma Collection Trust v Deutsches Patent- und Markenamt (C-650/17) | 1 | 0.00 |
| EURegulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal products (Codified version) (Text with EEA relevance ) | 1 | 0.00 |
| EUCouncil Regulation (EEC) No 1768/92 of 18 June 1992 concerning the creation of a supplementary protection certificate for medicinal products | 1 | 0.00 |
| EUGlaxosmithkline Biologicals SA and Glaxosmithkline Biologicals, Niederlassung der Smithkline Beecham Pharma GmbH & Co. KG v Comptroller General of Patents, Designs and Trade Marks (C-210/13) | 1 | 0.00 |
| EUAbraxis Bioscience LLC v Comptroller General of Patents (C-443/17) | 1 | 0.00 |